Maria Buti, MD, PhD
Medical degree at the University of Barcelona and her PhD in Internal Medicine at the University "Autónoma" de Barcelona, Spain. She is currently Professor of Medicine and Chief of Internal Medicine and Hepatology at the Hospital General Universitari Valle Hebron, Barcelona.

Maria Buti has received research support and/or honoraria for consulting and/or advisory boards from MSD, ABBVIe, BMS, Gilead and Novartis

Stanislas Pol, MD, PhD
Professor of Hepatology and Gastroenterology at Université Paris V (Paris Descartes), Paris, France. He is the Head of the Liver Unit and the Head of the medical and surgical departments of Gastro-Enterology and Hepatology at Cochin Hospital, Paris, France.

Stanislas Pol has received research support and/or honoraria for consulting and/or advisory boards from GSK, BMS, Boehringer Ingelheim, Tibotec /Janssen Cilag, Vertex, Novartis, Sanofi, Gilead, Roche, MSD and Abbott.

Jürgen Rockstroh, MD, PhD
Professor of Medicine, University of Bonn, Head, HIV and HIV/HCV Clinical Trials Unit Bonn, Germany.

Jürgen Rockstroh has received research support and/or honoraria for consulting and/or advisory boards from Abbott Laboratories, Abbvie, Boehringer Ingelheim Pharmaceuticals, Bristol-Myers Squibb Company, Cipla, Gilead Sciences Medical Affairs, Merck, Roche Laboratories, Tibotec and Viiv Healthcare.

Susanna Naggie, MD
Dr Susanna Naggie is an Associate Professor of Medicine at Duke University School of Medicine. She holds a joint appointment in the Section of GI/Hepatology Research at the Duke Clinical Research Institute where she is involved in Phase I-III Clinical Trials. She staffs two HIV/HCV coinfection multidisciplinary clinics at Duke and the Durham VA. She serves as an inpatient attending physician on ID consults and general internal medicine at the Durham VA Medical Center.

Research grants to her institution: Gilead, AbbVie, Janssen, Merck, BMS, Vertex. Consulting/advisory honoraria in past 2 years (ending 10/01/2015): Merck, AbbVie, BMS, Gilead.

Alessandra Mangia
Alessandra Mangia is Head of the Liver Unit at the Istituto di Ricovero e Cura a Carattere Scientifico ‘Casa Sollievo della Sofferenza' Hospital in San Giovanni Rotondo, Italy. She specialized in gastroenterology in 1986 at the Catholic University in Rome, Italy.

Alessandra Mangia has received research support and/or honoraria for consulting and/or advisory boards from BMS, Boehringer Ingelheim, Janssen Cilag, Novartis, Gilead sciences, Roche, and MSD.

Jordan Feld MD MPH
University of Toronto, Ontario, Canada
Dr. Feld graduated from medical school at the University of Toronto in 1997 and then completed residency programs in Internal Medicine and Gastroenterology. Following his clinical training, Dr. Feld focused on developing skills in clinical and laboratory research in liver disease, with a particular interest in viral hepatitis. He completed a clinical research fellowship in hepatology and then spent 4 years doing clinical and laboratory research in the Liver Diseases Branch of the National Institutes of Health. He received a Masters of Public Health with a focus on Infectious Diseases as a Sommer Scholar from Johns Hopkins University and has worked extensively abroad, maintaining a strong interest in International Health. Currently, Dr. Feld is clinician-scientist based at the Toronto Western Hospital Liver Clinic and the McLaughlin- Rotman Centre for Global Health.

Dr. Jordan Feld received personal fees for scientific consulting from: AbbVie, Bristol Myers Squibb, Gilead Sciences, Janssen and Merck, as well as grants for research from AbbVie, Gilead Sciences, Janssen, Merck and Abbott.

François Raffi, MD, PhD Project Coordinator
Professor of Infectious and Tropical Diseases University of Nantes Head, HIV Clinical Trials Unit Chief of the Department of Infectious Diseases Nantes, France

François Raffi has received research support and/or honoraria for consulting and/or advisory boards from Abbott Laboratories, Boehringer Ingelheim Pharmaceuticals, Bristol-Myers Squibb Company, Gilead Sciences Medical Affairs, GlaxoSmithKline, Merck & Co, Pfizer, Roche Laboratories, Tibotec and ViiV Healthcare.

Pedro Cahn, MD, PhD
Chief of the Department of Infectious Diseases Professor of Infectious and Tropical Diseases University of Buenos Aires Scientific Director Fundaciòn HUESPED Past President, International AIDS Society (IAS) Buenos Aires, Argentina

Pedro Cahn has received research support and/or honoraria for consulting and/or advisory boards from Abbott, Avexa, BMS, Boehringer Ingelheim, Gilead, GSK, Myriad, Merck, Pfizer, Pharmasset, Roche, Schering Plough and Tibotec.

Anton Pozniak, MD, FRCP
Consultant Physician and Honorary Senior Lecturer Director of HIV Services Chelsea and Westminster Hospital NHS Foundation Trust and Imperial College London, UK

Anton Pozniak has received research support and/or honoraria for consulting and/or advisory boards from Abbott Laboratories, Boehringer Ingelheim Pharmaceuticals, Bristol-Myers Squibb Company, Gilead Sciences Medical Affairs, Merck & Co, Roche Laboratories, Tibotec and Viiv Healthcare.